Does chromatin modulation provide the first wet biomarker for Huntington's disease?
Mov Disord
.
2012 Apr;27(4):473.
doi: 10.1002/mds.24914.
Author
Ralf Reilmann
1
Affiliation
1
EHDN Huntington Center Münster & EHDN Neuroprotective Therapy Working Group, Department of Neurology, University Clinic Muenster, Westfaelische-Wilhelms University of Muenster, Albert-Schweitzer Campus 1, Muenster, Germany.
PMID:
22590715
DOI:
10.1002/mds.24914
No abstract available
Publication types
Comment